Shing M Lee

15PUBLICATIONS

60CO-AUTHORS

Molecular targetsMulticultural, intercultural and cross-cultural studiesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsClinical pharmacy and pharmacy practice

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Jun 12, 2026

Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

|Apr 27, 2026

Return of results is important to heterogeneous research participants: A single-site survey.

|May 07, 2025

Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation.

Gulam A Manji, Liam J Stanton, Angela C Hirbe

|Apr 09, 2024

Dose optimization for cancer treatments with considerations for late-onset toxicities.

Lucie Biard, Anaïs Andrillon, Rebecca B Silva

|Nov 30, 2023

Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs.

Morgan R L Lichtenstein, Melissa P Beauchemin, Rohit Raghunathan

|Apr 21, 2023

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG).

Shing M Lee, Weijia Fan, Aijin Wang

Pageof 3

Frequent Collaborators

3 joint publications

Dawn L Hershman

2 joint publications

Melissa P Beauchemin

2 joint publications

Morgan R L Lichtenstein

Elena B Elkin

Jason D Wright

Brian A Van Tine

Gulam A Manji

Gary K Schwartz

Sahil Doshi

Liner Ge

Frequent Collaborators

3 joint publications

Dawn L Hershman

2 joint publications

Melissa P Beauchemin

2 joint publications

Morgan R L Lichtenstein

2 joint publications

Elena B Elkin